Check-Cap Ltd (F:7CC) — Market Cap & Net Worth
Market Cap & Net Worth: Check-Cap Ltd (7CC)
Check-Cap Ltd (F:7CC) has a market capitalization of $9.20 Million (€7.87 Million) as of September 16, 2026. Listed on the F stock exchange, this Germany-based company holds position #27380 globally and #2353 in its home market, demonstrating a 0.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Check-Cap Ltd's stock price €5.35 by its total outstanding shares 7730359 (7.73 Million). Also see Check-Cap Ltd assets under control for a full breakdown of the balance sheet.
Check-Cap Ltd Market Cap History: 2015 to 2026
Check-Cap Ltd's market capitalization history from 2015 to 2026. Data shows change from $3.73 Billion to $48.35 Million (-35.86% CAGR). Also see 7CC cash flow conversion for how efficiently the company converts equity into cash flow.
Check-Cap Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Check-Cap Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 7CC share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7CC by Market Capitalization
Companies near Check-Cap Ltd in the global market cap rankings as of September 16, 2026. Review tangible equity quality of Check-Cap Ltd to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Check-Cap Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #88 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $641.39 |
| #161 | Danaher Corporation | NYSE:DHR | $147.88 Billion | $209.36 |
| #476 | WuXi AppTec Co Ltd | SHG:603259 | $56.70 Billion | CN¥156.67 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $350.78 |
Check-Cap Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Check-Cap Ltd's market cap moved from $3.73 Billion to $ 48.35 Million, with a yearly change of -35.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €48.35 Million | +287.68% |
| 2025 | €12.47 Million | +36.63% |
| 2024 | €9.13 Million | -47.67% |
| 2023 | €17.44 Million | +2.34% |
| 2022 | €17.04 Million | -83.74% |
| 2021 | €104.84 Million | +111.68% |
| 2020 | €49.53 Million | -81.97% |
| 2019 | €274.74 Million | -10.06% |
| 2018 | €305.47 Million | -79.59% |
| 2017 | €1.50 Billion | -68.19% |
| 2016 | €4.70 Billion | +26.03% |
| 2015 | €3.73 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Check-Cap Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.20 Million USD |
| MoneyControl | $9.20 Million USD |
| MarketWatch | $9.20 Million USD |
| marketcap.company | $9.20 Million USD |
| Reuters | $9.20 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Check-Cap Ltd
Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.